Homocysteine

If your one-carbon metabolism, the network your cells use to recycle amino acids and methyl groups, is stumbling, homocysteine is often the first blood marker to show it. It rises when you are short on folate, vitamin B12, or vitamin B6, when your kidneys are struggling, or when a genetic variant is nudging your biochemistry off course. Because none of those clues appear on a routine metabolic panel, an unexplained elevation can be the fastest way to find a fixable problem.

The number matters clinically. Every 5 μmol/L rise in blood homocysteine is linked to roughly 34% higher all-cause mortality risk, and elevated levels are one of the more consistently replicated signals for stroke. It is not a perfect predictor, and the debate about how aggressively to treat mild elevations is real, but knowing your level gives you information that standard cholesterol, glucose, and CBC results cannot.

What Homocysteine Is

Homocysteine is a small molecule your cells create as a byproduct when they break down methionine, an amino acid you get from dietary protein. It is not a protein, hormone, or enzyme. It is a metabolic intermediate that either gets recycled back into methionine or converted onward to cysteine, depending on your cells' needs at the moment.

That recycling depends on B vitamins. The route back to methionine needs folate and vitamin B12. The route onward to cysteine needs vitamin B6. When any of these vitamins run short, homocysteine backs up in the bloodstream. Your kidneys clear it too, so kidney trouble also raises the level. This is why the test is a sensitive snapshot of B-vitamin status, kidney function, and one-carbon metabolism all at once.

Stroke and Cardiovascular Risk

Stroke is where the evidence for homocysteine is strongest. Pooling 21 studies, ischemic stroke patients had homocysteine levels averaging 3.70 μmol/L higher than controls. Even mild elevation appears to matter, with stroke severity and outcome beginning to worsen at higher levels. Umbrella analyses combining observational, genetic, and intervention data agree that the direction of effect is consistent across all three lines of evidence.

For broader cardiovascular disease, the story is more mixed. Moderate elevations are a modest predictor of first cardiovascular events, but randomized trials that lower homocysteine with B vitamins have generally not reduced heart attacks or overall cardiovascular deaths. A large trial of heart attack survivors cut homocysteine by 28% over nearly seven years and still saw no vascular benefit.

This apparent contradiction is not a paradox. Homocysteine reflects several underlying processes at once, and lowering the number without addressing the upstream cause, whether that is B12 deficiency, kidney disease, or a genetic variant, may not translate into fewer events. Think of the level as a signal to investigate, not as a target to hit at any cost. When elevated homocysteine reveals a real B-vitamin deficiency or kidney problem, correcting the underlying issue is what matters.

Mortality Signal

Homocysteine tracks mortality in a striking way. Meta-analysis of prospective cohorts found a linear relationship: risk of death from any cause rose 33.6% for every 5 μmol/L increase. In a community cohort, people in the higher homocysteine group had roughly 72% higher 10-year risk of dying from any cause than those in the lower group, and cardiovascular mortality rose incrementally with each 1 μmol/L rise.

This does not mean homocysteine directly kills you. It may partly reflect renal function, nutritional status, or systemic illness that independently drive mortality. But it does mean an elevated number is worth taking seriously as a general marker of how well your metabolism, kidneys, and vitamin economy are running.

Cognitive Decline and Alzheimer's Disease

Blood homocysteine has been repeatedly linked to Alzheimer-type dementia. A dose-response meta-analysis of prospective cohorts found that risk of Alzheimer-type dementia increased 15% for every 5 μmol/L rise in blood homocysteine. Evidence was weaker and less consistent for all-cause dementia and vascular dementia, so the strongest signal is for the Alzheimer subtype specifically.

Whether treatment helps is less settled. Supplementation with vitamins B6, B12, and folate consistently lowers homocysteine, with average declines of about 32% seen as early as one month, but the trials that measured cognitive endpoints did not deliver clean answers on whether cognition tracks along with the biomarker.

Kidney Function

The kidneys clear a large portion of circulating homocysteine, so declining renal function raises the level. This creates a two-way relationship: chronic kidney disease drives homocysteine up, and higher homocysteine tracks with worse cardiovascular outcomes in kidney patients. In one study of chronic limb-threatening ischemia, the apparent link between homocysteine and mortality weakened substantially after adjusting for kidney function, showing how much renal clearance shapes the number.

In practical terms, if your homocysteine is elevated and your kidney function is not being checked in parallel, you are missing half the story. Cystatin C or creatinine-based eGFR is the natural companion measurement.

B-Vitamin Deficiency

This is where homocysteine shines diagnostically. Total homocysteine is more sensitive than serum vitamin B12 alone for functional B12 deficiency. In patients with clinical B12 deficiency, both homocysteine and methylmalonic acid are markedly elevated in more than 98% of cases. Both metabolic markers outperform serum B12, because vitamin levels can look fine while cells still struggle to use the vitamin.

Folate deficiency also raises homocysteine, and treating the deficient vitamin brings the level back down. This makes homocysteine useful not just for diagnosis but for confirming that your intervention is actually working at the cellular level, rather than just changing the number in a supplement bottle.

Pregnancy and Fertility

Homocysteine is normally lower in pregnancy than in nonpregnant women. Elevated levels during pregnancy are linked to recurrent pregnancy loss, preeclampsia, preterm delivery, placental abruption, fetal growth restriction, and gestational diabetes. Findings are not perfectly consistent across studies, and homocysteine alone is a limited predictor because normal ranges shift with gestational age, ethnicity, nutrition, and genetics. Combined screening strategies that pair homocysteine with platelet parameters, uterine artery Doppler, or metabolic markers perform better than homocysteine on its own.

Homocystinuria

At the far end of the spectrum, markedly elevated homocysteine can point to homocystinuria, an inherited disorder of homocysteine metabolism. Classical severe hyperhomocysteinemia is caused by CBS gene mutations that block the transsulfuration pathway, the route that normally converts homocysteine into cysteine. Clinical features include lens dislocation, marfanoid skeletal appearance, osteoporosis, intellectual disability, and premature thromboembolic disease. Any young adult with unexplained thrombosis, connective tissue features, or lens dislocation and a severely elevated homocysteine warrants a metabolic workup.

Reconciling the Mixed Evidence

It can be confusing that observational studies link elevated homocysteine to worse outcomes while B-vitamin trials often fail to reduce heart attacks. The framework that makes both true: homocysteine is a phenotype marker, not a lever. It captures multiple upstream problems, and lowering the number alone does not necessarily fix those upstream problems. Where the underlying cause is a real B12, folate, or B6 deficiency, correction helps and homocysteine falls alongside. Where the cause is kidney disease, aging, or something else, lowering homocysteine with vitamins moves the number without changing the disease.

Tracking Your Trend

Homocysteine is a good marker for serial tracking because within-person variability is low. Short-term reliability coefficients run around 0.90 to 0.94, and intra-individual variation is about 8%. That means a single measurement gives you a reasonable snapshot of your average level, but a trend across two or more readings gives you far more confidence, especially since a change of about 25% is needed to be sure a difference is real rather than noise.

A reasonable cadence is to establish a baseline, retest in 3 to 6 months if you are addressing a deficiency or starting a medication known to affect the level, and check annually thereafter. If you are pregnant, on B-vitamin supplementation for cognitive or vascular reasons, or managing kidney disease, more frequent checks are worthwhile.

Decision Pathway When Elevated

An elevated homocysteine should trigger a workup, not a shrug. Order or review companion tests to find the cause: vitamin B12, folate, and vitamin B6 status; methylmalonic acid to separate B12-related from folate-related causes; kidney function via creatinine and cystatin C; TSH to rule out hypothyroidism; and a review of medications known to raise the level. If the elevation is severe and cannot be explained by these, consider testing for MTHFR variants and getting a metabolic specialist involved.

The pattern of findings matters more than the number in isolation. Elevated homocysteine with low B12 and high methylmalonic acid points to functional B12 deficiency. Elevated homocysteine with reduced eGFR points to renal contribution. Elevated homocysteine with normal vitamins, normal kidneys, and a family history of premature vascular disease or thrombosis warrants a closer look at genetics.

When Results Can Be Misleading

The single biggest source of falsely elevated results is delayed sample processing. Homocysteine rises about 10% per hour at room temperature after the blood is drawn, because your red blood cells keep making and releasing it. If the plasma is not separated from cells within 30 minutes, or the sample is not chilled immediately, the result can drift from normal to abnormal purely from handling.

• Recent exercise: acute exercise transiently raises homocysteine by about 1.18 μmol/L on average, with individual studies showing increases roughly in the 9% to 26% range depending on intensity, returning to baseline within 24 hours. If you tested within a day of a hard workout, the result may be inflated.
• Posture during draw: lying down for 30 minutes before the draw lowers measured homocysteine by about 6%. Serial tests should use consistent posture.
• Recent meals: nonfasting samples show a modest decrease in the first hours after eating and an increase after about 8 hours. Fasting samples reduce this noise.
• Assay differences: different laboratory methods can disagree by up to 13% on average, and specific platforms can differ by 30% at the extremes. Try to use the same lab and method across serial tests.

Age, Sex, and Genetics

Homocysteine tends to run about 1 μmol/L higher in men than women at every age, and both sexes see a marked rise after age 50. The MTHFR C677T variant, especially the TT genotype, also raises baseline levels. None of these are conditions to treat directly, but they shape what a normal value looks like for you personally and reinforce why comparing your number to your own past results is more useful than comparing it to a population average.